| HOME >> MEDICINE >> TECHNOLOGY |
47,09428,877Selling and marketing
89,94775,112General and administrative
88,72339,732Contingent consideration
40,39911,316Amortization of intangible assets
24,83214,492Restructuring and divestiture
16,687(71)Impairment of goodwill
5,826-Acquired in-process research and development
4,500-Other expenses
12320632,251393,624(Loss) income from operations
(43,703)73,421Interest expense
(56,673)(29,079)Other income (expense), net
2,412(2,736)(Loss) income before provision for income taxes
(97,964)41,606(Benefit) provision for income taxes
(20,197)14,037Net (loss) income
$
(77,767)$
27,569Net (loss) income per share: Basic
$
(0.29)$
.11Diluted
$
(0.29)$
.10Weighted average number of shares outstanding:Basic
264,938262,164Diluted
264,938264,878(1) Stock-based compensation included in costs and expenses during the three months ended September 29, 2012 was $2,120 for cost of revenues, $1,640 for research and development, $2,121 for selling and marketing, $4,831 for general and administrative and $3,500 for restructuring. Stock-based compensation included in costs and expenses during the three months ended
'/>"/>SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved
Related medicine technology :
1. Hologic to Showcase Advancement Simplifying Removal of Large Intrauterine Pathology at AAGL
2. Hologic, Inc. Marks Breast Cancer Awareness Month by Ringing the Opening Bell at NASDAQ and Taking 3D Mammography on the Road
3. Hologic Announces Verdict In Patent Infringement Suit
4. Hologic To Participate In The Morgan Stanley Global Healthcare Conference
5. Senator Blumenthal, a Strong Advocate for Womens Health, Visits Hologics Manufacturing Facility in Danbury, CT
6. Hologic Completes Acquisition Of Gen-Probe
7. Hologic Announces Third Quarter Fiscal 2012 Operating Results
8. Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe
9. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
10. Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologics Acquisition of Gen-Probe
11. Hologic And Gen-Probe Provide Update On Pending Transaction